EUVIMEDOpdag EUVIMED
Open access · CC BY 4.0

Intact microdissection of stellate ganglia in a Parkinson's disease model reveals aggregation of mutant human α‐synuclein in their cell bodies

Bonn Lee, Shiraz Ahmad, Charlotte E Edling, Fiona E N LeBeau, Kamalan Jeevaratnam iD

Experimental Physiology · 2025-06 · 110 (6) · 866-876

DOI: 10.1113/ep092261 ↗

At a glance

Journal article in Experimental Physiology, published online on 2025-02-21. Written by Bonn Lee and 4 co-authors. Institution: School of Veterinary Medicine, Faculty of Health and Medical Sciences, University of Surrey, Guildford, UK. Major MEDLINE topics: alpha-Synuclein, Parkinson Disease, Stellate Ganglion. Cited 1 times so far (Crossref); 50 references. The full text is freely available (open access, CC BY 4.0). Funded by: University of Surrey, British Heart Foundation.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Cardiac dysautonomia plays an important role in understanding Parkinson's disease (PD), with recent studies highlighting the presence of α‐synuclein in cardiac tissue. We hypothesise that sympathetic dysregulation observed in PD may involve pathological changes caused by α‐synuclein in stellate ganglia (SG). This study aimed to investigate α‐synucleinopathy in SG of the genetic PD murine animal model. Mice overexpressing Ala30Pro (A30P) mutant α‐synuclein were used. We here demonstrate a technique for meticulously dissecting SG. The collected SG from the transgenic mice were immunolabelled with neuronal markers, A30P human mutant α‐synuclein and anti‐α‐synuclein aggregates. A30P mutant α‐synuclein protein was expressed in the sympathetic neuronal (tyrosine hydroxylase (TH)‐positive) cell bodies. Approximately 27% of the TH‐positive cell bodies expressed the A30P mutant α‐synuclein protein. The mutant protein was densely localised at the cardiopulmonary pole of the SG. Additionally, we observed that the A30P mutant protein formed fibril aggregation in the SG. Our findings suggest that α‐synucleinopathy in the PD animal model can affect the sympathetic autonomic nervous system, providing insight for further research into targeting α‐synuclein pathology in the SG as a potential link between cardiac dysautonomia and PD.

Subjects

MeSH terms (MEDLINE)

alpha-SynucleinParkinson DiseaseStellate GanglionAnimalsMice, TransgenicHumansMiceDisease Models, AnimalMutationTyrosine 3-MonooxygenaseProtein Aggregation, PathologicalNeuronsMale

Author keywords

Parkinson's diseaseSUDPARcardiac dysautonomiastellate gangliaα‐synuclein

Substances

alpha-SynucleinTyrosine 3-Monooxygenase

Authors and institutions

  • School of Veterinary Medicine, Faculty of Health and Medical Sciences, University of Surrey, Guildford, UK.
  • Biosciences Institute, Faculty of Medical Sciences, University of Newcastle, The Medical School, Newcastle upon Tyne, UK.

ORCID profiles: Kamalan Jeevaratnam

Funding

  • University of Surrey
  • British Heart Foundation

Cite

APA

Lee, B., Ahmad, S., Edling, C. E., LeBeau, F. E. N., & Jeevaratnam, K. (2025). Intact microdissection of stellate ganglia in a Parkinson's disease model reveals aggregation of mutant human α‐synuclein in their cell bodies. Experimental Physiology, 110(6), 866-876. https://doi.org/10.1113/ep092261

Vancouver

Lee B, Ahmad S, Edling CE, LeBeau FEN, Jeevaratnam K. Intact microdissection of stellate ganglia in a Parkinson's disease model reveals aggregation of mutant human α‐synuclein in their cell bodies. Experimental Physiology. 2025;110(6):866-876. doi:10.1113/ep092261

BibTeX
@article{Lee2025,
  author = {Lee, Bonn and Ahmad, Shiraz and Edling, Charlotte E and LeBeau, Fiona E N and Jeevaratnam, Kamalan},
  title = {Intact microdissection of stellate ganglia in a Parkinson's disease model reveals aggregation of mutant human α‐synuclein in their cell bodies},
  journal = {Experimental Physiology},
  year = {2025},
  volume = {110},
  number = {6},
  pages = {866--876},
  doi = {10.1113/ep092261}
}
Start for free →